[email protected]

01252 375362

01252 375362

  • About Us
    • About Pharmacy Consulting
    • Our Team
    • Work With Us
    • Testimonials
  • Consultancy
    • For Pharmaceutical Wholesalers
    • For Pharmacies
    • Care Quality Commission – CQC
    • Pharmaceutical Manufacturers
    • Medical Devices Consultancy and Training
  • Academy Training
  • Bespoke Training
  • Making Pharmaceuticals Show
  • Our CPD
    • Blog
    • Editorial Items
    • Social Media
  • Contact Us
Remote Auditing versus On Site Auditing

Remote Auditing versus On Site Auditing

by Charlotte Abbott | Jul 22, 2021 | Audit, Blog

Remote Auditing versus On Site Auditing: For the last 16 months the pharmaceutical world has had to get used to remote auditing as opposed to auditing in person.

Risk Assessments – Evaluating hazards

Risk Assessments – Evaluating hazards

by Charlotte Abbott | Jul 22, 2021 | Blog, Risk Assessments

Risk Assessments: The aim of writing one is to evaluate hazards, then remove that hazard or minimise the level of its risk by adding control measures, as necessary.

WDA(H) & Import – New Guidelines:

WDA(H) & Import – New Guidelines:

by Sally Finlayson | Jul 21, 2021 | Blog, Brexit, GDP/RP, MHRA, RP, Training, WDA(H)

Following Brexit and GB leaving the EU the MHRA have advised that GB wholesale dealers now need to appoint an RPi

API registration

API registration

by Steven Hewison | Jul 21, 2021 | API Registration, Blog

API registration is an MHRA requirement if you manufacture, import or distribute active substances and you are based in the UK.

New Contract RP introduction

New Contract RP introduction

by Steven Hewison | Jul 21, 2021 | Blog, MHRA, RP

New Contract RP says hello! Please allow me to introduce myself as the newest member of PCL’s Contract RP Team.

Export & WDA(H) – Updated Guidelines:

Export & WDA(H) – Updated Guidelines:

by Sally Finlayson | Jul 14, 2021 | Blog, Export Training, MHRA, WDA(H), WDA(H)

As Great Britain (GB) are no longer part of the European Union (EU) since the 1st of January 2021 exit date. It is essential to ensure all the necessary changes have been made to remain MHRA compliant.

« Older Entries
Next Entries »

Recent Posts

  • Medical Devices: Conformity Assessment and the UKCA Mark
  • Are Audit clip boards and checklists obsolete?
  • Major Changes to MHRA Medical Device Registration Fees

Upcoming Courses

  • GDP Audit Online Training on 9 March 2026 10:00 am
  • Export Online Training on 12 March 2026 10:00 am
  • Understanding GPhC Guidance for Online Pharmacies – Online Training on 16 March 2026
  • GDP/RP Cogent Gold Standard Online Training on 17 March 2026
  • GDP/RP Cogent Gold Standard WEEKEND Training on 20 March 2026 9:30 am

MHRA Alerts & Recalls

MHRA Safety Roundup: February 2026
25 February 2026
Class 4 Medicines Defect Notification: Rayner Pharmaceuticals Limited, Dropodex 0.1% w/v Eye Drops, solution, EL(26)A/10
24 February 2026
Field Safety Notices: 16-20 February 2026
24 February 2026
Class 2 Medicines Recall: Sterling Pharmaceuticals Ltd (specials manufacturer MS 32515), KidNaps (Melatonin) 1mg in 1ml Oral Solution, EL(26)A/09
23 February 2026

Get In Touch

Address:
Wellesley House
10 Eelmoor Road
Farnborough
Hampshire
GU14 7QN

Phone: 01252 375362
Email: [email protected]
  • Terms and Conditions
  • Privacy Policy

Designed by Four Lakes

  • Follow
  • Follow
  • Follow
  • Follow